Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.66 --0%
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
VIVO, PMCB, PLCE, More
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($1.26), $0.11 worse than the analyst estimate of ($1.15).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- DA Davidson Reiterates Buy Rating on Barrick Gold Corp. (GOLD)
- Barclays sees reasons to take risk off the table in September
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
